We are a clinical stage, emerging specialty pharmaceutical company developing, manufacturing and eventually commercializing products based on our proprietary PLEX™ (Polymer-Lipid Encapsulation matriX) platform in the field of extended release, local drug delivery.
These products are intended to address some of modern medicine’s main challenges, where current local or systemic administration has limited effect, is too toxic, or both.
The PLEX™ (Polymer-Lipid Encapsulation matriX) platform is a matrix made of alternating layers of polymers and lipids that entrap a therapeutic drug between them in order to form a protected reservoir that enables an effective localized drug delivery at the target site.
PLEX-based drug reservoirs enable prolonged delivery of unmodified drugs over periods ranging from days to several months. The application of our PLEX™ technology enables to optimize drug treatment regimens by predetermining release rates and durations, a rare combination of attributes.
The PLEX™ platform is able to accommodate a large variety of different molecules, regardless of size or physical characteristics:
We invite companies to partner with us by utilizing our PLEX™ platform as a local drug delivery vehicle that will optimize their drugs’ therapeutic effect and clinical outcome. We offer fast and easy partnering process: